Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
GlobeNewswire, Inc.
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing.
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
GlobeNewswire, Inc.
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and TANDEM data - - European...
SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma
GlobeNewswire, Inc.
BRUSSELS, July 01, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company designed to address rare and urgent conditions, today announced that it has completed the acquisition of exclusive development and...
SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million
GlobeNewswire, Inc.
BRUSSELS, May 19, 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development and...
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
GlobeNewswire, Inc.
Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients.
New Memoranda pave the way for €50 million in investments in local development and public health
Government of Slovenia
SLOVENIA, May 18 - The Memoranda were signed by His Excellency Vegard Kaale, Ambassador of the Kingdom of Norway, Her Excellency Helga Hauksdóttir, Ambassador of Iceland, representing the Donor States, i.e., the Kingdom of Norway, the Principality...
4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner
GlobeNewswire, Inc.
Thera Liechtenstein brings extensive biotech investment and company‑building experience to new role as Partner at 4BIO Capital Tetsu Maruyama, former Head of Drug Discovery at Takeda Pharmaceuticals, appointed as Venture Partner London, United...
Obyte Introduces Coop: A Decentralized Community System to Reward Meaningful Contributions
EIN Presswire
Vote for contributors who help Obyte grow, receive votes for your own contributions, and earn daily emissions of COOP tokens in proportion to votes received VADUZ, LIECHTENSTEIN, August 14, 2026 /EINPresswire.com/ -- Obyte is glad to announce...
European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union
GlobeNewswire, Inc.
Data indicate that the 2026-2027 COVID-19 vaccine formula, targeting the XFG variant, induces a strong immune response against contemporary circulating and emerging lineages More than five billion doses of the Pfizer-BioNTech COVID-19 vaccines...
American Fusion Inc. (OTC: AMFN) Appoints John Gerdin to Board of Directors as Independent Director and Strategic Advisor
GlobeNewswire, Inc.
SOUTHLAKE, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- American Fusion Inc. (OTC: AMFN) ("American Fusion" or the "Company"), developer of the proprietary Texatron™ Fusion Engine™, announced today that John Gerdin has been appointed to the Company’s...
Virella Files European Patent Application for Novel SIRT6 Small-Molecule Activators
EIN Presswire
Liechtenstein-based biotech company reports significant lifespan extension in C. elegans and advances toward preclinical development with CRO partners SCHAAN, LIECHTENSTEIN, April 3, 2026 /EINPresswire.com/ -- Virella Ltd, a European biotech...
European Commission’s Approval of CinnaGen’s Teriparatide Signals New Phase of Global Growth
EIN Presswire
The European Commission’s authorization of Zandoriah®, an osteoporosis medication, marks a significant step in CinnaGen’s journey of international expansion DUBAI, DUBAI, UNITED ARAB EMIRATES, July 3, 2026 /EINPresswire.com/ -- July 02, 2026:...
The European Magazine Releases Its Summer 2026 Edition
EIN Presswire
The Summer 2026 edition of The European is out now. Order your print or digital copy for exclusive interviews, expert analysis and global insights.
Remarks by Treasury Secretary Scott Bessent before the American Swiss Foundation
U.S. Department of the Treasury
Good afternoon.
Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration
GlobeNewswire, Inc.
New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) represents a rare achievement that reinforces the urgent...
ESSEPA research illustrates the current state of safeguarding in university sport
EIN Presswire
The research reveals a paradox: while the frameworks often assume safety, participants on the ground report a fragmented system with unclear reporting and gaps.
European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
GlobeNewswire, Inc.
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric patients aged 12 years and older First European...
Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
GlobeNewswire, Inc.
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and...
Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
GlobeNewswire, Inc.
If approved, Joenja® (leniolisib) would become the first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on Phase II/III clinical data...
AMERICAN SWISS FOUNDATION HOSTS AMBASSADOR FAITH WHITTLESEY LEADERSHIP DINNER IN RÜSCHLIKON, SWITZERLAND
EIN Presswire
RÜSCHLIKON, ZÜRICH, SWITZERLAND, July 2, 2026 /EINPresswire.com/ -- On June 16th, the American Swiss Foundation (ASF) hosted the Ambassador Faith Whittlesey Leadership Award Dinner in Rüschikon, bringing together more than 100 alumni, leaders,...
Sign up for:
Health Monitor Liechtenstein
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.